Clinical Trial

TIVA Versus Balanced Anesthesia on Muscle Mass in CRC Surgery

Study acronym: TIVABAL-CRC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 19, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is aimed at clarifying changes in body composition during the perioperative period and identifying risk factors for skeletal muscle mass loss in patients with colorectal cancer. The investigators will asess the impact of the type of anaesthesia (total intravenous anaesthesia/sevoflurane anaesthesia) for colorectal surgery on the muscle function and mass, which will be evaluated using ultrasound, dynamometry and bioimpedance.
Trial Details
NCT Number NCT07237438
Lead Sponsor Grigore T. Popa University of Medicine and Pharmacy
Collaborators: Regional Institute of Oncology, Iasi, Romania
Conditions Colorectal Cancer (CRC), Sarcopenia
Enrollment 40 participants
Start Date 2025-09-20
Primary Completion 2026-02 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-11-19